CAS 1788901-86-9

Lenvatinib N-Oxide (6-carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide)

CAS: 1788901-86-9

Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticides

Fórmula: C₂₁H₁₉ClN₄O₅

Cor e Forma: Yellow Solid

Peso molecular: 442.1044

Ref: 45-1A03800

LenvatinibN-Oxide

CAS: 1788901-86-9

Fórmula: C₂₁H₁₉ClN₄O₅

Pureza: 95%

Cor e Forma: Solid

Peso molecular: 442.8524

Ref: IN-DA01E2UD

6-Carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide

CAS: 1788901-86-9

6-Carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide

Pureza: 95%

Peso molecular: 442.86g/mol

Ref: 54-OR1048658

Lenvatinib N-Oxide

CAS: 1788901-86-9

Fórmula: C₂₁H₁₉ClN₄O₅

Cor e Forma: Yellow Solid

Peso molecular: 442.86

Ref: 4Z-L-124005

Lenvatinib N-Oxide

Produto Controlado

CAS: 1788901-86-9

Applications Lenvatinib N-Oxide is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
References Matsui, J., et al.: Clin. Cancer Res., 14, 5459 (2008); Gild, M., et al.: Nature Rev. Endocrinol., 7, 617 (2011)

Fórmula: C₂₁H₁₉ClN₄O₅

Cor e Forma: Neat

Peso molecular: 442.85

Ref: TR-L329500

Lenvatinib N-Oxide

CAS: 1788901-86-9

Fórmula: C₂₁H₁₉ClN₄O₅

Peso molecular: 442.86

Ref: ST-EA-CP-L14006